| 2004 Press Releases
December 15, 2004
Late registration with the Public Company Accounting Oversight Board (PCAOB) by Health Discovery Corporation's former audit firm results in the Company being listed as "non-compliant"
November 30, 2004
Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation, Invited to Appear Live on the Steve Crowley American Scene Financial Talk Radio Program.
November 23, 2004
Health Discovery Corporation Announces Filing of Patent Application Covering Gene Biomarkers for Prostate Cancer
November 15, 2004
Health Discovery Corporation to Present its New Biomarker Discoveries for Prostate Cancer, Benign Prostatic Hyperplasia (BPH), AIDS, and Leukemia at the Upcoming NIBA Conference
November 8, 2004
Health Discovery Corporation Announces Discovery Of New Gene Biomarkers For Prostate Cancer
November 8, 2004
Health Discovery Corporation announces Discovery Of New Gene Biomarkers For BPH (Benign Prostatic Hyperplasia)
September 20, 2004
Health Discovery Corporation Announces the Filing of Additional Patents for Newly Discovered Biomarkers in HIV Infection and New Biomarker Discovery Tools
September 7, 2004
New Patent Expands Health Discovery Corporation's Intellectual Property Portfolio for Support Vector Machines
August 25, 2004
8K Filed - Health Discovery Corporation Wins Appeal
August 9, 2004
Health Discovery Corporation Announces Filing of Patent Applications for New Biomarker Discovery in HIV-Infection, Leukemia and Down's Syndrome
August 3, 2004
Health Discovery Corporation Acquires Rights To patent Portfolio That Includes Issued Pioneer patents On Support Vector Machines
August 2, 2004
Health Discovery Corporation Announces completion of $1.5 Million Private Placement
July 20, 2004
Health Discovery Corporation Presents Their Recent Biomarker Discovery in AIDS at the SCI2004 Conference in Orlando
July 19, 2004
Health Discovery Corporation Calls a Meeting of its Scientific Advisory Board to review Recent Biomarker Discoveries
July 14, 2004
Dr. Ken Welsh, Professor of Clinical Genomics, Royal Brompton Hospital and Imperial College, London England, Named to Health Discovery Corporation Scientific Advisory Board
July 13, 2004
Humboldt Research Award Winner Professor Dr. Vladimir Vapnik, Named to Health Discovery Corporation Scientific Advisory Board
July 06, 2004
Dr. Thomas A. Stamey, World Renowned Urologist and Prostate Cancer Expert, Named to Health Discovery Corporation Scientific Advisory Board
June 22, 2004
Standard & Poor's Approves Health Discovery Corporation for Listing in the Premier Market Access Program
June 21, 2004
Health Discovery Corporation files Form 8-K for Direct Wireless Communications Inc.
June 10, 2004
Health Discovery Corporation files Form 8-K for Direct Wireless Communications Inc.
May 24, 2004
Stephen D. Barnhill, M.D., CEO of Health Discovery Corporation Presents "Biomarkers for Drug Discovery and Diagnostic Tests" at the Clinical Ligand Assay Society Annual Meeting in Chicago.
May 12, 2004
Health Discovery Corporation Announces New Website
April 30, 2004
Health Discovery Corporation Announces Presentation of Fractal Genomics Modeling Technology at National Institutes of Health
April 7, 2004
Health Discovery Corporation Announces Participation in the SCIA Conference
March 30, 2004
Direct Wireless Communications Inc Files SEC form 10KSB, Annual Report
March 23, 2004
Health Discovery Corporation Announces Agreement with the University of Miami for Biomarker and Pathway Discovery in AIDS Related Dementia
March 22, 2004
Health Discovery Corporation Announces Agreement With Stanford University for Biomarker and Pathway Discovery in Lymphatic Insufficiency
January 27, 2004
Dr. Herbert A. Fritsche, Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at M.D. Anderson Cancer Center Accepts Position as Chairman of the Scientific Advisory Board of Health Discovery Corporation
January 26, 2004
Health Discovery Corp. announces Agreement With M.D. Anderson Cancer Center for Biomarker and Pathway Discovery in Prostate Cancer
January 20, 2004
Health Discovery Corp. Files SEC form 8-K, Acquisition or Disposition of Assets
January 8, 2004
Health Discovery Corp. Releases Shareholder Letter
January 2, 2004
Health Discovery Corporation Completes the Acquisition of Fractal Genomics
|